---
title: 'Driving performance and ocular activity following acute administration of
  10â€‰mg methylphenidate: A randomised, double-blind, placebo-controlled study'
date: '2024-10-12'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39394668/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241013183215&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Methylphenidate mitigates performance decrements typically
  associated with prolonged and monotonous driving. The absence of pronounced oculomotor
  effects suggests that a single 10 mg dose of methylphenidate has no deleterious
  impact on visual scanning behaviour during driving tasks with low-to-moderate cognitive
  demand. Future research should investigate the effects of methylphenidate under
  various dosing and driving conditions to better understand its ...'
disable_comments: true
---
CONCLUSIONS: Methylphenidate mitigates performance decrements typically associated with prolonged and monotonous driving. The absence of pronounced oculomotor effects suggests that a single 10 mg dose of methylphenidate has no deleterious impact on visual scanning behaviour during driving tasks with low-to-moderate cognitive demand. Future research should investigate the effects of methylphenidate under various dosing and driving conditions to better understand its ...